Episode 30: VTE and AF at ESC 2025

About this episode

Dr Barnes and Dr Marco Proietti discuss key studies from ESC 2025 that may impact clinical practice.

“I think this was such an important trial, certainly one that has changed my practice already.” Dr Barnes welcomes Dr Marco Proietti for a review and discussion of key studies presented at ESC 2025, including AMALFI, ALONE-AF, and HI-PRO. Which results were practice-changing, which were reassuring, and which are of uncertain value or highlight a need for new therapeutics?

People in this episode

Host: Dr Barnes

Guest: Dr Marco Proietti

Topics covered

• VTE
• AF
• ESC 2025
• clinical trials
• practice-changing results
• therapeutics

Keywords

• VTE
• AF
• ESC 2025
• AMALFI
• ALONE-AF
• HI-PRO
• clinical trials
• therapeutics

Mentioned in this episode

Books & works: AMALFI, ALONE-AF, HI-PRO

More episodes of Thrombosis in conversation

• Episode 33: The emotional toll of VTE: A patient’s perspective · December 4, 2025 · 25 min
• Episode 32: 2025 breakthroughs in VTE and AF · November 26, 2025 · 27 min
• Episode 31: Optimising treatment duration for thrombosis · October 10, 2025 · 26 min
• Episode 29: Individualised care in special populations · March 18, 2025 · 20 min
• Episode 28: Real-world evidence: Addressing gaps in VTE and AF clinical research · March 6, 2025 · 20 min
• Episode 27: A multidisciplinary approach to CAT · February 18, 2025 · 15 min